logo
On Mounjaro, US comedian Rosie O'Donnell shows off weight loss: Is the drug safe for 60-plus women?

On Mounjaro, US comedian Rosie O'Donnell shows off weight loss: Is the drug safe for 60-plus women?

Indian Express6 days ago

American comedian and talk show host Rosie O'Donnell, 63, stunned everybody with her weight loss transformation post, looking visibly slender from her plump self that viewers have been used to. She made an admission too, that she had been on the weight loss drug tirzepatide, sold under the brand name Mounjaro. 'I can't believe this is me now,' she captioned the photo.
In an earlier interaction on social media, she had said, 'I've lost more weight. I am on Mounjaro for my diabetes and one of the side effects is you lose weight.' Apart from medication, she also switched over to home-cooked meals, avoided sugar and drank more water. What makes her two-year journey unique is the fact that she started on her weight loss journey after 60. The question is should a 60-year-old, post-menopausal woman start on a regime of Mounjaro? 'Yes, it is perfectly safe to start Mounjaro at that age,' says Dr Richa Chaturvedi, endocrinologist at Indraprastha Apollo Hospitals, New Delhi.
Mounjaro or tirzepatide, which is now available in India, mimics the function of natural hormones GIP and GLP-1. It has a double effect, of increasing insulin secretion in response to food intake and improving glucose control and weight loss. It is officially approved for Type 2 diabetes and weight loss in people with obesity or overweight plus related health conditions.
Current clinical trials have shown similar efficacy and safety profiles for all test cases over the age of 18. However, due to age-related metabolism and co-morbidities, older patients may need a more customised approach. 'It is safe for people over 60 but we generally do not prescribe it for those over 70 because there are limited studies on this,' says Dr Anoop Misra, chairman, Fortis C-DOC for Diabetes and Allied Sciences, New Delhi.
He advises caution. 'Tirzepatide should not be used by people with type 1 diabetes, severe kidney or liver disease, personal or family history of thyroid cancer and severe gastrointestinal disorders like pancreatitis,' he says. Also a protocol would depend on what other medication the patient is on.
A UK study by Voy and the Imperial College of London has shown that women over 55 outperform even younger people on weight loss drugs. That's because they tracked their health better. 'If taking Mounjaro at a late age, make sure that the patient has a high-protein diet to stabilise blood sugar and preserve lean muscle mass. If the elderly lose muscle mass, they become more prone to falls and broken bones. Rapid weight loss can cause bones to lose density and strength. This has to be coupled with strength training. Some squats, lunges, calf raises and weight routines should be done other than walking,' says Dr Chaturvedi.
As these drugs can induce stomach paralysis, users, according to her, should have enough water as dehydration can cause the elderly to feel faint and fall.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Woman sheds 4 stone(25 kilos) in 4 months on Mounjaro, then suffers liver failure—how the drug works and its risks
Woman sheds 4 stone(25 kilos) in 4 months on Mounjaro, then suffers liver failure—how the drug works and its risks

Time of India

time27 minutes ago

  • Time of India

Woman sheds 4 stone(25 kilos) in 4 months on Mounjaro, then suffers liver failure—how the drug works and its risks

Aimee Chapman, 34, from Southampton, lost four stone in just four months using Mounjaro—but her rapid transformation came at a devastating cost. The former waitress was admitted to intensive care last summer with liver failure and a perforated oesophagus, complications doctors directly linked to the weight-loss injection. Tired of too many ads? go ad free now Chapman had purchased Mounjaro from a major online pharmacy in March 2024, hoping that losing weight would help her be 'taken more seriously' by doctors after being diagnosed with fibromyalgia, a chronic pain disorder. At first, the results were everything she hoped for. But just a few months in, her health began to unravel. "I couldn't really do much. I was only eating a couple of times a week," she said. "I stopped being able to walk. I would take a couple of steps and have to stop. Then I couldn't stop being sick. I was throwing up all the time and started throwing up blood. I was sick between 50 and 60 times." Chapman collapsed multiple times. "My husband came home and found me passed out on the hallway one night," she said. Initially, she believed it was a virus. 'I was in a bit of denial about it being linked to the jab because I was fine up until now.' It wasn't until she experienced severe chest pains that she went to Winchester Hospital A&E. There, doctors discovered a hole in her oesophagus—allowing air to leak around her heart and lungs. As her blood pressure and potassium levels dropped, she was transferred to intensive care at Southampton General Hospital, where doctors found her liver was 'failing.' A transplant was considered. "They had said it was down to the weight-loss jab but they didn't know why or how to fix it," she said. "I was terrified. It all happened so quickly… I was told the hole in the oesophagus can kill people and I may have needed a new liver. Tired of too many ads? go ad free now They said I could've died." Though her condition was stabilized within two weeks, her ordeal continued. By September, she began losing large clumps of hair—eventually diagnosed as a vitamin B12 deficiency. 'It kept happening and the handfuls kept getting bigger. I would be so sad,' she said. 'My hair was such a massive part of my identity and to cut it off just felt really traumatic.' While she doesn't want to 'tell people what they can and can't take,' Chapman says, 'I regret ever taking them. I'd say to other people thinking about trying them, don't do it online, go through your doctor who can give you blood tests and check how you're doing.' What exactly is Mounjara? According to Mounjaro (tirzepatide) is a once-weekly injection primarily prescribed to manage type 2 diabetes by lowering blood sugar levels. In addition to its intended purpose, the medication is also known to promote weight loss. It is meant to be used alongside a healthy diet and regular exercise. The U.S. Food and Drug Administration (FDA) approved Mounjaro on May 13, 2022, and got a at the end of 2023 for weight loss in adults. Currently, there is no generic version available. Tirzepatide is sold under two brand names—Mounjaro and Zepbound—both manufactured by Eli Lilly and Company. While they contain the same active ingredient, they are approved for different medical uses. How does Mounjaro work? According to the National Library of Medicine, mounjaro (tirzepatide) works through a unique dual-action approach by targeting two key gut hormone receptors. Here's how it helps manage blood sugar and promote weight loss: Activates Two Hormone Receptors Slows Down Stomach Emptying Controls Appetite Increases Satiety Influences Brain Reward Pathways What are the known side effects? Like many medications in its class, Mounjaro is associated with a range of side effects, most of which involve the gastrointestinal (GI) system. According to Eli Lilly and Co. and the U.S. Food and Drug Administration ( ), the most commonly reported side effects include: Nausea Vomiting Diarrhea Constipation Abdominal pain or discomfort Decreased appetite Indigestion or heartburn

31 killed by Israeli gunfire near aid center in S Gaza
31 killed by Israeli gunfire near aid center in S Gaza

United News of India

timean hour ago

  • United News of India

31 killed by Israeli gunfire near aid center in S Gaza

Gaza, June 1 (UNI) At least 31 Palestinians were killed on Sunday by Israeli gunfire near a humanitarian aid center in southern Gaza. At least 31 people were killed and dozens of others seriously injured in the morning when Israeli forces opened fire near a humanitarian aid distribution point in Rafah, southern Gaza, where residents were gathering to receive aid, Gaza-based health authority said in a statement. Most of the injuries were in the upper body, and the death toll could rise due to the severity of the wounds, said Mohammed Abu Afash, director of the Medical Relief Organization in Gaza, adding that ambulances have difficulty reaching the scene due to ongoing Israeli military activities. Eyewitnesses told media that thousands of people had arrived at the aid center since early morning hours when gunfire and explosions erupted. Calling the incident part of a "pattern of repeated targeting" of aid distribution locations by Israel, the Hamas-run Gaza government media office said in a press statement that the area was operating in coordination with an American-Israeli company and under the supervision of Israeli forces. Also on Sunday, the Israel Defense Forces said in a statement that it is unaware of injuries caused by its fire within the Humanitarian Aid distribution site, and that the matter is still under review. Israeli media cited military sources as saying that Israeli military operations in the area were aimed at targeting "terrorist elements." Israel closed border crossings and curtailed the flow of humanitarian aid into Gaza on March 2. Limited access has been permitted since May 22. Israel resumed its assault on Gaza on March 18, following a two-month truce with Hamas. Since then, 4,149 Palestinians have been killed and 12,149 injured, according to Gaza-based health authorities on Sunday. UNI XC GNK

Chronic stress contributes to cognitive decline and dementia risk – two healthy-ageing experts explain what you can do about it
Chronic stress contributes to cognitive decline and dementia risk – two healthy-ageing experts explain what you can do about it

The Hindu

timean hour ago

  • The Hindu

Chronic stress contributes to cognitive decline and dementia risk – two healthy-ageing experts explain what you can do about it

The probability of any American having dementia in their lifetime may be far greater than previously thought. For instance, a 2025 study that tracked a large sample of American adults across more than three decades found that their average likelihood of developing dementia between ages 55 to 95 was 42%, and that figure was even higher among women, Black adults and those with genetic risk. Now, a great deal of attention is being paid to how to stave off cognitive decline in the ageing American population. But what is often missing from this conversation is the role that chronic stress can play in how well people age from a cognitive standpoint, as well as everybody's risk for dementia. We are professors at Penn State in the Center for Healthy Aging, with expertise in health psychology and neuropsychology. We study the pathways by which chronic psychological stress influences the risk of dementia and how it influences the ability to stay healthy as people age. Recent research shows that Americans who are currently middle-aged or older report experiencing more frequent stressful events than previous generations. A key driver behind this increase appears to be rising economic and job insecurity, especially in the wake of the 2007-2009 Great Recession and ongoing shifts in the labour market. Many people stay in the workforce longer due to financial necessity, as Americans are living longer and face greater challenges covering basic expenses in later life. Therefore, it may be more important than ever to understand the pathways by which stress influences cognitive ageing. Social isolation and stress Although everyone experiences some stress in daily life, some people experience stress that is more intense, persistent or prolonged. It is this relatively chronic stress that is most consistently linked with poorer health. In a recent review paper, our team summarised how chronic stress is a hidden but powerful factor underlying cognitive aging, or the speed at which your cognitive performance slows down with age. It is hard to overstate the impact of stress on your cognitive health as you age. This is in part because your psychological, behavioural and biological responses to everyday stressful events are closely intertwined, and each can amplify and interact with the other. For instance, living alone can be stressful – particularly for older adults – and being isolated makes it more difficult to live a healthy lifestyle, as well as to detect and get help for signs of cognitive decline. Moreover, stressful experiences – and your reactions to them – can make it harder to sleep well and to engage in other healthy behaviors, like getting enough exercise and maintaining a healthy diet. In turn, insufficient sleep and a lack of physical activity can make it harder to cope with stressful experiences. Stress is often missing from dementia prevention efforts A robust body of research highlights the importance of at least 14 different factors that relate to your risk of Alzheimer's disease, a common and devastating form of dementia and other forms of dementia. Although some of these factors may be outside of your control, such as diabetes or depression, many of these factors involve things that people do, such as physical activity, healthy eating and social engagement. What is less well-recognised is that chronic stress is intimately interwoven with all of these factors that relate to dementia risk. Our work and research by others that we reviewed in our recent paper demonstrate that chronic stress can affect brain function and physiology, influence mood and make it harder to maintain healthy habits. Yet, dementia prevention efforts rarely address stress. Avoiding stressful events and difficult life circumstances is typically not an option. Where and how you live and work plays a major role in how much stress you experience. For example, people with lower incomes, less education or those living in disadvantaged neighborhoods often face more frequent stress and have fewer forms of support – such as nearby clinics, access to healthy food, reliable transportation or safe places to exercise or socialise – to help them manage the challenges of aging. As shown in recent work on brain health in rural and underserved communities, these conditions can shape whether people have the chance to stay healthy as they age. Over time, the effects of stress tend to build up, wearing down the body's systems and shaping long-term emotional and social habits. Lifestyle changes to manage stress and lessen dementia risk The good news is that there are multiple things that can be done to slow or prevent dementia, and our review suggests that these can be enhanced if the role of stress is better understood. Whether you are a young, midlife or an older adult, it is not too early or too late to address the implications of stress on brain health and ageing. Here are a few ways you can take direct actions to help manage your level of stress: - Follow lifestyle behaviors that can improve healthy ageing. These include: following ahealthy diet, engaging in physical activity and getting enough sleep. Even small changes in these domains can make a big difference. - Prioritise your mental health and well-being to the extent you can. Things as simple as talking about your worries, asking for support from friends and family and going outside regularly can be immensely valuable. - If your doctor says that you or someone you care about should follow a new health care regimen, or suggests there are signs of cognitive impairment, ask them what support or advice they have for managing related stress. - If you or a loved one feel socially isolated, consider how small shifts could make a difference. For instance, research suggests that adding just one extra interaction a day – even if it's a text message or a brief phone call – can be helpful, and that even interactions with people you don't know well, such as at a coffee shop or doctor's office, can have meaningful benefits. Walkable neighborhoods, lifelong learning A 2025 study identified stress as one of 17 overlapping factors that affect the odds of developing any brain disease, including stroke, late-life depression and dementia. This work suggests that addressing stress and overlapping issues such as loneliness may have additional health benefits as well. However, not all individuals or families are able to make big changes on their own. Research suggests that community-level and workplace interventions can reduce the risk of dementia. For example, safe and walkable neighborhoods and opportunities for social connection and lifelong learning – such as through community classes and events – have the potential to reduce stress and promote brain health. Importantly, researchers have estimated that even a modest delay in disease onset of Alzheimer's would save hundreds of thousands of dollars for every American affected. Thus, providing incentives to companies who offer stress management resources could ultimately save money as well as help people age more healthfully. In addition, stress related to the stigma around mental health and aging can discourage people from seeking support that would benefit them. Even just thinking about your risk of dementia can be stressful in itself. Things can be done about this, too. For instance, normalising the use of hearing aids and integrating reports of perceived memory and mental health issues into routine primary care and workplace wellness programs could encourage people to engage with preventive services earlier. Although research on potential biomedical treatments is ongoing and important, there is currently no cure for Alzheimer's disease. However, if interventions aimed at reducing stress were prioritised in guidelines for dementia prevention, the benefits could be far-reaching, resulting in both delayed disease onset and improved quality of life for millions of people. Jennifer E. Graham-Engeland is professor of Biobehavioural Health, Penn State. Her email is jeg32@ Martin J. Sliwinski is Professor of Human Development and Family Studies, Penn State. His email is mjs56@ (This article is republished from The Conversation under a Creative Commons license. Read the original article here:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store